Neurological Death is Common in Patients With EGFR Mutant Non-Small Cell Lung Cancer Diagnosed With Brain Metastases
2019 · Advances in Radiation Oncology · 15 citations
https://doi.org/10.1016/j.adro.2019.11.002
M
Matthew Ramotar
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
28
Papers
122
Citations
7
h-index
6
i10-index
Matthew Ramotar is an academic researcher from University Health Network. The author has contributed to research in topics: Prostate Cancer Treatment and Research & Prostate Cancer Diagnosis and Treatment & Brain Metastases and Treatment. The author has an h-index of 7, co-authored 24 publications.
ORCID: 0000-0003-4179-0523Papers by this author
worksOral pimonidazole unveils clinicopathologic and epigenetic features of hypoxic tumour aggressiveness in localized prostate cancer
2024 · BMC Cancer · 2 citations
https://doi.org/10.1186/s12885-024-12505-1
The Terry Fox Research Institute Marathon of Hope Cancer Centres Network: A pan-Canadian precision oncology initiative
2025 · Cancer Cell · 2 citations
https://doi.org/10.1016/j.ccell.2025.03.014
Oligometastasis in Prostate Cancer: Can We Learn from Those “Excluded” from a Phase 2 Trial?
2023 · European Urology Open Science · 0 citations
https://doi.org/10.1016/j.euros.2023.03.016
Clinical Outcomes for Standard of Care Machine Learning Prostate Radiotherapy Treatment Planning
2024 · International Journal of Radiation Oncology*Biology*Physics · 0 citations
https://doi.org/10.1016/j.ijrobp.2024.07.017
3304 Outcomes for Human versus Machine Learning Prostate-Only Radiation Therapy Treatment Planning
2025 · Radiotherapy and Oncology · 0 citations
https://doi.org/10.1016/s0167-8140(25)01615-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat